Commentary by Aaron Lord MD, Copy Editor, Clinical Correlations
The medical news event of the week was of course the early termination of the glucose control arm of the ACCORD trial, which showed increased …
Commentary by Aaron Lord MD, Copy Editor, Clinical Correlations
The medical news event of the week was of course the early termination of the glucose control arm of the ACCORD trial, which showed increased …
Commentary by Melissa Freeman MD, Endocrinology Section Editor
The ACCORD trial is an ongoing 5-year, North American, randomized study that began in 2001 to evaluate potential interventions to decrease cardiovascular (CV) events in …
Posted By: Vivian Hayashi, MD, Instructor of Clinical Medicine, Division of General Internal Medicine and Robert Smith, MD Associate Professor of Medicine, Division Pulmonary and Critical Care Medicine
The answer to the mystery quiz is lung cancer, in particular, adenocarcinoma with a predominantly bronchoalveolar cell pattern (BAC). The clue to the mystery was …
Commentary By: Joshua Olstein, MD Associate Editor, Clinical Correlations
Let’s begin this week by congratulating the Superbowl XLII champion New York Giants on an excellent victory. As Americans wakes up the day after and begin to recover from …
Commentary By: Steven Sedlis, MD Associate Professor of Medicine, Chief, Division of Cardiology Manhattan Veterans Administration Medical Center
This year’s AHA meeting was held in November in Orlando Florida. The cardiology fellows …
Commentary by Elizabeth Haskins MD, PGY-3
This week’s Grand Rounds was delivered by Dr. Tomas Berl, Chief of the Nephrology Division at the University of Colorado Health Sciences Center in Denver. Dr. Berl’s current …
Posted By: Vivian Hayashi, MD, Instructor of Clinical Medicine, Division of General Internal Medicine and Robert Smith, MD Associate Professor of Medicine, Division Pulmonary and Critical Care Medicine
A 78 year old man with a history of ankylosing spondylitis and known cardiac disease associated with congestive heart failure, presented with breathlessness one year …
Commentary by Henry Tran, MD
Old adage: just because it’s new doesn’t necessarily mean it’s better. The FDA approved the usage of drug-eluting stents (DES) in 2003 and these stents were quickly embraced …